The G1 checkpoint cyclin-dependent kinase inhibitor 1B (CDKN1B, p27kip1, or p27) plays a crucial role in tumor suppression by binding to and preventing the activation of cyclin E-CDK2 complexes, thus inhibiting abnormal cell cycle progression [62]. This evidence concerns the gene CDKN1B and neoplasm.